Phospholipid Autoantibodies (Nonanticardiolipin)-Antiprothrombin Antibodies

Autoantibodies: Third Edition

Volumn , Issue , 2013, Pages 741-749

  Pregnolato, Francesca ^a   Chighizola, Cecilia B ^a  

^a ISTITUTO AUXOLOGICO ITALIANO   (Italy)

Author keywords

Antiphosphatidylserine prothrombin antibodies; Antiphospholipid syndrome; Antiprothrombin antibodies; Lupus anticoagulant; Miscarriages; Thrombosis

Indexed keywords

EID: 84902047745     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-444-56378-1.00088-5     Document Type: Chapter

References (33)

1. Amengual O., Atsumi T., Koike K. Specificities, properties and clinical significance of antiprothrombin antibodies. Arthritis Rheum 2003, 48:886-895.
2. Atsumi T., Amengual O., Yasuda S., Koike T. Antiprothrombin antibodies - are they worth assaying?. Thromb Res 2004, 114:533-538.
3. Arvieux J., Darnige L., Caron C., et al. Development of an ELISA for autoantibodies to prothrombin showing their prevalence in patients with lupus anticoagulants. Thromb Haemost 1995, 74:1120-1125.
4. Matsuda J., Saitoh N., Gotoh M., et al. Phosphatidylserine-dependent antiprothrombin antibody is exclusive to patients with lupus anticoagulant. Br J Rheumatol 1996, 35:589-591.
5. Galli M., Beretta G., Daldossi M., et al. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb Haemost 1997, 77:486-491.
6. Bevers E.M., Zwaal R.F.A., Willems G.M. The effect of phospholipids on the formation of immune complexes between autoantibodies and β2 glycoprotein I or prothrombin. Clin Immunol 2004, 112:150-160.
7. Vega-Ostertag M., Liu X., Kwan-Ki H., et al. A human monoclonal anti-prothrombin antibody is thrombogenic in vivo and upregulates expression of tissue factor and E-selectin on endothelial cells. Br J Haematol 2006, 135:214-219.
8. Fleck R.A., Rapaport S.I., Rao L.V.M. Anti-prothrombin antibodies and the lupus anticoagulant. Blood 1988, 72:512-519.
9. Pengo V., Biasiolo A., Brocco T., et al. Autoantibodies to phospholipid-binding plasma proteins in patients with thrombosis and phospholipid-reactive antibodies. Thromb Haemost 1996, 75:721-724.
10. Horback D.A., van Oort E., Donders R.C., et al. Lupus anticoagulant is the strongest risk factors for both venous and arterial thrombosis in patients with systemic lupus erythematosus. Comparison between different assays for the detection of antiphospholipid antibodies. Thromb Haemost 1996, 76:916-924.
11. Swadzba J., De Clerck L.S., Stevens W.L., et al. Anti-cardiolipin, antibeta2glycoprotein I, antiprothrombin antibodies, and lupus anticoagulant in patients with systemic lupus erythematosus with a history of thrombosis. J Rheumatol 1997, 24:1710-1715.
12. Palosuo T., Virtamo J., Haukka J., et al. High antibody levels to prothrombin antibody imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men. Thromb Haemost 1997, 1178-1182.
13. Forastiero R., Martinuzzo M.E., Adamczuk Y., et al. Occurrence of anti-prothrombin antibodies in and anti-beta2glycoprotein I antibodies in patients with a history of thrombosis. J Lab Clin Med 1999, 134:610-615.
14. Munoz-Rodriguez F.J., Reverter J.C., Font J., et al. Prevalence and clinical significance of anti-prothrombin antibodies in patients with systemic lupus erythematosus or with primary anti-phospholipid syndrome. Haematologica 2000, 85:632-637.
15. Atsumi T., Ieko M., Bertolaccini M.L., et al. Association of autoantibodies against the phosphatidylserine-prothrombin complex with manifestations of the antiphospholipid syndrome and in the presence of lupus anticoagulant. Arthritis Rheum 2000, 43:1982-1993.
16. Nojima H., Kuratsune H., Suehisa E., et al. Anti-prothrombin antibodies combined with lupus anticoagulant activity is an essential risk factor for venous thromboembolism in patients with systemic lupus erythematosus. Br J Haematol 2001, 114:647-654.
17. Simmelink M.J.A., De Groot P.G., Derksen R.H.W.M. A study on associations between antiprothrombin antibodies, antiplasminogen antibodies and thrombosis. J Thromb Haemost 2002, 1:735-739.
18. Von Landenberg P., Matthias T., Zaech J., et al. Anti-prothrombin antibodies are associated with pregnancy loss in patients with the antiphospholipid syndrome. Am J Reprod Med 2003, 49:51-56.
19. Ishikura K., Wada H., Kamikura Y., et al. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis. Am J Hematol 2004, 76:338-342.
20. Bertolaccini M.L., Atsumi T., Koike T., et al. Antiprothrombin antibodies detected in two different assay systems. Prevalence and clinical significance I systemic lupus erythematosus. Thromb Haemost 2005, 93:289-297.
21. Bizzaro N., Tonutti E., Villalta D., et al. Prevalence and clinical correlation of anti-phospholipid binding protein antibodies in anti-cardiolipin negative patients with systemic lupus erythematosus and women with unexplained recurrent miscarriages. Arch Pathol Lab Med 2005, 129:61-68.
22. Tsutumi A., Hayashi T., Chino Y., et al. Significance of anti-prothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the anti-phosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays. Mod Rheumatol 2006, 16:158-164.
23. Forastiero R., Martinuzzo M., Pombo G., et al. A prospective study of antibodies to β2-glycoprotein I and prothrombin, and risk of thrombosis. J Thromb Haemost 2005, 3:1231-1238.
24. Bizzaro N., Ghirardello A., Zampieri S., et al. Anti-prothrombin antibodies predict thrombosis in patients with systemic lupus erythematosus: a 15 year longitudinal study. J Thromb Haemost 2007, 5:1158-1164.
25. Jaskowski T.D., Wilson A.R., Hill H.R., et al. Autoantibodies against phosphatidylserine, prothrombin and phosphatidylserine-prothrombin complex: identical or distinct tools for antiphospholipid syndrome?. Clin Chim Acta 2009, 410:19-24.
26. Pengo V., Denas G., Bison E., et al. Prevalence and significance of anti-prothrombin antibodies in patients with lupus anticoagulant (LA). Thromb Res 2010, 126:150-153.
27. Marozio L., Curti A., Botta G., et al. Anti-prothrombin antibodies are associated with adverse pregnancy outcome. Am J Reprod Immunol 2011, 66:404-409.
28. Hoxha A., Ruffatti A., Pittoni M. The clinical significance of autoantibodies directed against prothrombin in primary antiphospholipid syndrome. Clin Chim Acta 2012, 413:911-913.
29. Sater M.S., Finan R.R., Abu-Hijleh F.M., et al. Anti-phosphatidylserine, anti-cardiolipin, anti-β2glycoprotein I and anti-prothrombin antibodies in recurrent miscarriage at 8-12 gestational weeks. Eur J Obstet Gynecol Reprod Biol 2012, 136:170-174.
30. Zigon P., Ambrozic A., Cucnik S., et al. Modified phosphatidylserine-dependent antithrombin ELISA enables identification of patients negative for other antiphospholipid antibodies and also detect low avidity antibodies. Clin Chem Lab Med 2011, 49:1011-1018.
31. Galli M., Luciani D., Bertolini G., et al. Anti-β2glycoprotein I, anti-prothrombin antibodies, and the risk of thrombosis in the antiphospholipid syndrome. Blood 2003, 102:2717-2723.
32. Atsumi T., Koike T. Antiprothrombin antibody: why do we need more assays?. Lupus 2010, 19:436-439.
33. Lakos G., Kiss E., Regeczy N., et al. Anti-prothrombin and anti-annexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases. J Rheumatol 2000, 27:924-929.